close

Enter

Log in using OpenID

Epilepsy Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast

embed
Global Epilepsy Therapeutics Market is estimated to value over USD 15.2 billion by 2026 end and register a CAGR of over 3.2% during the forecast period 2019 to 2026.
Epilepsy Therapeutics Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Global Epilepsy Therapeutics Market is estimated to value over USD 15.2 billion by
2026 end and register a CAGR of over 3.2% during the forecast period 2019 to 2026.
The global epilepsy therapeutics market size is inflating at a high growth rate due to
an ever-growing ageing population, increase in research and development activities
in developing as well as developed markets and adoption of anti-epileptics owing to
an increased number of epilepsy and seizure cases.
As per the WHO, epilepsy affects more than 40 million people across the world. In
epilepsy, the brain starts to act abnormally, thus leading to frequent seizures that are
short spans of involuntary movements, which may involve the entire body or a body
part. These seizures sometimes result in causing unconsciousness and loss of bowel
control or bladder function. Treatment with surgery or medication can curb these
seizures in patients suffering from epilepsy.
Anti-epileptics are provided to treat epilepsy by curbing down seizures, and these
medications work by decreasing the recurrent brain impulses that cause pain and
seizures. High occurrence of epilepsy, increase in the prevalence of injuries to the
brain and the increasing ageing population are crucial factors steering the epilepsy
therapeutics market growth. Moreover, increased efficacy of future therapeutics
related to epilepsy and growing acceptance and awareness of advanced medications
amongst the patient population are predicted to stimulate the market in the
upcoming years.
The hospital pharmacies are predicted to subjugate the global market. Usually, for
treatment and diagnosis of neurology-based disorders, patients take advice from a
specialist and therefore, the hospital pharmacy is considered for prescription-based
medication. This can be credited to the major share accounted by the segment in the
market.
The North American Region is Predicted to Dominate the Global Market
North America is projected to dominate and account for a prominent global epilepsy
therapeutics market share. The North American region is prominently steered by a
rising patient pool, a high number of incidences related to neurological disorders,
injuries to the brain and increase in the number of epilepsy cases. Furthermore,
developing products of high efficacy, better outcomes and having fewer side-effects
shall possibly escalate the market growth in the region. The Asia Pacific region is
predicted to inflate with a noteworthy growth rate over the forecast period. This is
owing to the ever-increasing geriatric population base, initiatives taken by the
government in order to improve the healthcare industry, increasing activities related
to research and development and increasing prevalence of epilepsy in the Asia
Pacific region.
Key market players included in the global epilepsy therapeutics industry are Pfizer
Inc., UCB S.A, Bausch Health Companies Inc., Novartis AG, GlaxoSmithKline PLC, Teva
Pharmaceutical Industries, Sunovion Pharmaceuticals Inc., Eisai Co. Ltd., UpsherSmith Laboratories LLC, Amneal Pharmaceuticals LLC.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=3472&page=requestsample
Global Epilepsy Therapeutics Market Segmentation:
By Product



First Generation Epilepsy Therapeutics
Second Generation Epilepsy Therapeutics
Third Generation Epilepsy Therapeutics
By Distribution Channel



Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region





North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Purchase a Copy & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=3472&page=askfordiscount
FutureWise Key Takeaways:




Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth
Objectives of the Study:





To provide with an exhaustive analysis on the global epilepsy therapeutics
market by product, by distribution channel and by region
To cater comprehensive information on factors impacting market growth
(drivers, restraints, industry-specific restraints and opportunities)
To forecast and evaluate micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North
America, Europe, Asia Pacific, Latin America and Middle East & Africa
To record, evaluate and analyse competitive landscape mappingtechnological advancements, product launches, expansions and mergers
Browse Corresponding Healthcare Market Research Reports & Consulting
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content